Harborside


RIV Capital Inc.

CNSX: RIV


Canadian symbol: RIV.CN
US symbol: CNPOF

Currency in CAD

Valuation Measures4

Market Cap (intraday) 78.63M
Enterprise Value -9.37M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)18.97
Price/Book (mrq)0.30
Enterprise Value/Revenue -3.39
Enterprise Value/EBITDA 0.58

Trading Information

Stock Price History

Beta (5Y Monthly) 1.64
52-Week Change 3-68.63%
S&P500 52-Week Change 3-16.88%
52 Week High 31.8700
52 Week Low 30.0000
50-Day Moving Average 30.5475
200-Day Moving Average 31.0326

Share Statistics

Avg Vol (3 month) 343.35k
Avg Vol (10 day) 317.76k
Shares Outstanding 5163.8M
Implied Shares Outstanding 6N/A
Float 8108.43M
% Held by Insiders 115.48%
% Held by Institutions 132.17%
Shares Short (Aug 14, 2022) 4110.86k
Short Ratio (Aug 14, 2022) 42.42
Short % of Float (Aug 14, 2022) 4N/A
Short % of Shares Outstanding (Aug 14, 2022) 40.07%
Shares Short (prior month Jul 14, 2022) 4102.85k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 30, 2022
Most Recent Quarter (mrq)Jun 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-466.98%

Management Effectiveness

Return on Assets (ttm)-2.38%
Return on Equity (ttm)-7.67%

Income Statement

Revenue (ttm)2.81M
Revenue Per Share (ttm)0.02
Quarterly Revenue Growth (yoy)205.20%
Gross Profit (ttm)1.9M
EBITDA -12.42M
Net Income Avi to Common (ttm)-19.9M
Diluted EPS (ttm)-0.3700
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)171.54M
Total Cash Per Share (mrq)1.05
Total Debt (mrq)106.25M
Total Debt/Equity (mrq)36.35
Current Ratio (mrq)4.32
Book Value Per Share (mrq)1.78

Cash Flow Statement

Operating Cash Flow (ttm)-10.82M
Levered Free Cash Flow (ttm)19.81M

mrq = Most Recent Quarter
ttm = Trailing Twelve Months
yoy = Year Over Year
lfy = Last Fiscal Year
fye = Fiscal Year Ending
fy = Forward Year
Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.

Fundamentals are updated every day.
Full screen




Cannabis Market and Business News

Real-time cannabis business news from hundreds of sources. Never miss the news that matters the most.




Company News Date
RIV.CN
RIV Capital
2 days ago
RIV.CN
RIV Capital
1 month ago
RIV.CN
RIV Capital
1 month ago
RIV.CN
RIV Capital
3 months ago
RIV.CN
RIV Capital
3 months ago
RIV.CN
RIV Capital
5 months ago
RIV.CN
RIV Capital
5 months ago
RIV.CN
RIV Capital
5 months ago
RIV.CN
RIV Capital
5 months ago
RIV.CN
RIV Capital
5 months ago
RIV.CN
RIV Capital
9 months ago
RIV.CN
RIV Capital
10 months ago
RIV.CN
RIV Capital
10 months ago
RIV.CN
RIV Capital
1 year ago
RIV.CN
RIV Capital
1 year ago
RIV.CN
RIV Capital
1 year ago
RIV.CN
RIV Capital
1 year ago
RIV.CN
RIV Capital
1 year ago
RIV.CN
RIV Capital
1 year ago
RIV.CN
RIV Capital
1 year ago
RIV.CN
RIV Capital
1 year ago
RIV.CN
RIV Capital
1 year ago
RIV.CN
RIV Capital
1 year ago
RIV.CN
RIV Capital
1 year ago
RIV.CN
RIV Capital
1 year ago
RIV.CN
RIV Capital
1 year ago
RIV.CN
RIV Capital
1 year ago
RIV.CN
RIV Capital
1 year ago
RIV.CN
RIV Capital
1 year ago
RIV.CN
RIV Capital
1 year ago
RIV.CN
RIV Capital
1 year ago
RIV.CN
RIV Capital
1 year ago
RIV.CN
RIV Capital
1 year ago
RIV.CN
RIV Capital
1 year ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
2 years ago
RIV.CN
RIV Capital
3 years ago
RIV.CN
RIV Capital
3 years ago
RIV.CN
RIV Capital
3 years ago
RIV.CN
RIV Capital
3 years ago
RIV.CN
RIV Capital
3 years ago
RIV.CN
RIV Capital
3 years ago
RIV.CN
RIV Capital
3 years ago
RIV.CN
RIV Capital
3 years ago
RIV.CN
RIV Capital
3 years ago
RIV.CN
RIV Capital
3 years ago
RIV.CN
RIV Capital
3 years ago
RIV.CN
RIV Capital
3 years ago
RIV.CN
RIV Capital
3 years ago
RIV.CN
RIV Capital
3 years ago
RIV.CN
RIV Capital
3 years ago
RIV.CN
RIV Capital
3 years ago
RIV.CN
RIV Capital
3 years ago
RIV.CN
RIV Capital
3 years ago
RIV.CN
RIV Capital
3 years ago
RIV.CN
RIV Capital
3 years ago
RIV.CN
RIV Capital
3 years ago
RIV.CN
RIV Capital
3 years ago
RIV.CN
RIV Capital
3 years ago
RIV.CN
RIV Capital
3 years ago
RIV.CN
RIV Capital
3 years ago

Currency in CAD
Earnings EstimateCurrent Qtr.Next Qtr.Current YearNext Year
No. of Analysts0000
Avg. Estimate0000
Low Estimate0000
High Estimate0000
Year Ago EPSN/AN/AN/AN/A
Revenue EstimateCurrent Qtr.Next Qtr.Current YearNext Year
No. of Analysts0000
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings HistoryInvalid DateInvalid DateInvalid DateInvalid Date
EPS Est.N/AN/AN/AN/A
EPS ActualN/AN/AN/AN/A
DifferenceN/AN/AN/AN/A
Surprise %N/AN/AN/AN/A
EPS TrendCurrent Qtr.Next Qtr.Current YearNext Year
Current Estimate0000
7 Days Ago0000
30 Days Ago0000
60 Days Ago0000
90 Days Ago0000
EPS RevisionsCurrent Qtr.Next Qtr.Current YearNext Year
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesRIV.CNIndustrySector(s)S&P 500
Current Qtr.N/AN/AN/AN/A
Next Qtr.N/AN/AN/AN/A
Current YearN/AN/AN/AN/A
Next YearN/AN/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A


Insiders transactions are updated every hour.

Major Holders

Currency in CAD
Breakdown
15.48%% of Shares Held by All Insider
32.17%% of Shares Held by Institutions
38.07%% of Float Held by Institutions
8Number of Institutions Holding Shares

Top Institutional Holders

HolderSharesDate Reported% OutValue
AdvisorShares Investments, LLC9,698,390Mar 30, 20226.81%4,655,227
Tocqueville Asset Management L.p.70,400Jun 29, 20220.05%33,791
Gofen & Glossberg LLC50,000Jun 29, 20220.04%23,999
Horrell Capital Management, Inc.1,500Jun 29, 20220.00%719

Top Mutual Fund Holders

HolderSharesDate Reported% OutValue
AdvisorShares Trust-AdvisorShares Pure Cannabis ETF4,985,540Aug 30, 20223.50%2,393,059
AdvisorShares Trust-AdvisorShares Pure US Cannabis ETF4,512,850Jun 29, 20223.17%2,166,167
Amplify Seymour Cannabis ETF1,319,982Apr 29, 20220.93%633,591
Coming Soon

Search SEDAR Filings

Company Name:
Document Type:
Start Date:
End Date:

Press Releases by RIV Capital Inc.


Independent Proxy Advisory Firm ISS Recommends Shareholders Vote FOR RIV Capital's Board

Independent Proxy Advisory Firm ISS Recommends Shareholders Vote FOR RIV Capital’s Board

Institutional Shareholder Services joins Glass Lewis in support of all seven of the Company's Board nominees. RIV Capital's Board nominees are well equipped with the relevant industry expertise, experience and qualifications to execute on RIV Capital's strategic vision to become a leader in the cannabis market. Vote FOR RIV Capital's Boa... Read More...
Independent Proxy Advisory Firm Glass Lewis Endorses RIV Capital's Board of Directors

Independent Proxy Advisory Firm Glass Lewis Endorses RIV Capital’s Board of Directors

Independent proxy advisory firm Glass Lewis recommends shareholders vote FOR RIV Capital's highly qualified Board nominees. RIV Capital's visionary and highly experienced Board nominees bring diverse views, financial and capital market experience, and an understanding of the cannabis market in both Canada and the U.S.; they are committed... Read More...
RIV Capital Signs Lease for Flagship Cannabis Cultivation and Manufacturing Facility in Buffalo, New York

RIV Capital Signs Lease for Flagship Cannabis Cultivation and Manufacturing Facility in Buffalo, New York

TORONTO, Aug. 23, 2022 - RIV Capital Inc. (the "Company") (CSE: RIV) (OTC: CNPOF), a cannabis packaged goods company with a focus on establishing one of the strongest portfolios of brands in key strategic U.S. markets, acting through its wholly owned indirect subsidiary, RIV Capital US Real Estate LLC ("RIV Real Estate", together with the... Read More...
RIV Capital Reports Fourth Quarter and Fiscal Year 2022 Financial Results

RIV Capital Reports Fourth Quarter and Fiscal Year 2022 Financial Results

Previously Announced Acquisition of Etain Represents Initial Step to Becoming Licensed, Vertically-Integrated U.S. Cannabis Operator Strong Liquidity, Robust Balance Sheet, and Appointment of Mike Totzke as Chief Operating Officer Competitively Position RIV Capital for Operationalizing Strategy in U.S. Market  TORONTO, June 13, 2022 - RIV... Read More...
RIV Capital sets date for fourth quarter and fiscal year 2022 financial results

RIV Capital sets date for fourth quarter and fiscal year 2022 financial results

TORONTO, June 7, 2022 - RIV Capital Inc. (the "Company" or "RIV Capital") (CSE: RIV) (OTC: CNPOF) will report its financial results for the fourth quarter and fiscal year ended March 31, 2022 before markets open on Monday, June 13, 2022. The Company's audited consolidated financial statements and management's discussion and analysis for t... Read More...
RIV Capital announces receipt of application in connection with Etain acquisition

RIV Capital announces receipt of application in connection with Etain acquisition

TORONTO, May 24, 2022 - RIV Capital Inc. (CSE: RIV) (OTC: CNPOF) ("RIV Capital") today announced that it had received notice of an Ontario Superior Court of Justice application by JW Asset Management ("JWAM") in connection with the Company's process regarding its acquisition of ownership and control of Etain, LLC and Etain IP LLC, owners ... Read More...
RIV Capital to acquire New York-based Etain, names new CEO to lead entry and expansion in U.S. cannabis market

RIV Capital to acquire New York-based Etain, names new CEO to lead entry and expansion in U.S. cannabis market

Transformative transaction will include one of only 10 vertically integrated licences in New York and four active dispensaries with plans to bolster operations in advance of adult-use market Names Mark Sims, former SVP of Strategy and M&A for the Scotts Miracle-Gro Company, as President and CEO The Hawthorne Collective to advance an ... Read More...
Riv Capital Sets Date For Third Quarter Fiscal Year 2022 Financial Results

Riv Capital Sets Date For Third Quarter Fiscal Year 2022 Financial Results

TORONTO, Feb. 24, 2022 - RIV Capital Inc. (the "Company" or "RIV Capital") (CSE: RIV) (OTC: CNPOF) will report its financial results for the quarter ended December 31, 2021 ("Q3 2022") before markets open on Tuesday, March 1, 2022. The Company's unaudited condensed interim consolidated financial statements and management's discussion and ... Read More...
RIV Capital Reports Second Quarter Fiscal Year 2022 Financial Results

RIV Capital Reports Second Quarter Fiscal Year 2022 Financial Results

Strategic investment of US$150 million by The Hawthorne Collective highlights quarter Cash balance of $400 million available to launch U.S. platform  Discussions continue with shortlist of potential acquisition targets in strategic U.S. markets TORONTO, Nov. 18, 2021 - RIV Capital Inc. ("RIV Capital" or the "Company") (TSX: RIV) (OTC: CNP... Read More...
RIV Capital Sets Date For Second Quarter Fiscal Year 2022 Financial Results

RIV Capital Sets Date For Second Quarter Fiscal Year 2022 Financial Results

TORONTO, Nov. 4, 2021 - RIV Capital Inc. (the "Company" or "RIV Capital") (CSE: RIV) (OTC: CNPOF) will report its financial results for the quarter ended September 30, 2021 ("Q2 2022") before markets open on Thursday, November 18, 2021. The Company's unaudited condensed interim consolidated financial statements and management's discussion... Read More...
RIV Capital Announces Results of Annual General and Special Meeting of Shareholders

RIV Capital Announces Results of Annual General and Special Meeting of Shareholders

TORONTO, Sept. 30, 2021 - RIV Capital Inc. (the "Company") (CSE: RIV) (OTC: CNPOF) announced the voting results of its annual general and special meeting of shareholders (the "Meeting") held today. Shareholders voted in favour of three items of business before the Meeting, those being the election of the director nominees listed in the Co... Read More...
RIV Capital Receives ~$6.5 Million Upon Termination of PharmHouse's CCAA Proceedings

RIV Capital Receives ~$6.5 Million Upon Termination of PharmHouse’s CCAA Proceedings

TORONTO, Sept. 13, 2021 - RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF) today announced that it has received a cash distribution of approximately $6.5 million and that termination of PharmHouse Inc.'s ("PharmHouse") proceedings under the Companies' Creditors Arrangement Act (Canada) (the "CCAA Proceedings") and... Read More...
RIV Capital Announces AGM Date

RIV Capital Announces AGM Date

TORONTO, Sept. 9, 2021 - RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF) will hold its annual general and special meeting (the "Meeting") of shareholders of the Company ("Shareholders") on September 30, 2021 at 10 a.m. (EDT). Electronic copies of all materials related to the Meeting can be found on the Company's ... Read More...
RIV Capital Closes US$150 Million Strategic Investment by The Hawthorne Collective

RIV Capital Closes US$150 Million Strategic Investment by The Hawthorne Collective

Investment strengthens balance sheet, accelerating RIV Capital's strategy to build a multistate cannabis operating and brand platform through acquisitions RIV Capital common shares listed on the CSE and voluntarily de-listed from the TSX TORONTO, Aug. 25, 2021 - RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF) is ... Read More...
RIV Capital Reports First Quarter Fiscal Year 2022 Financial Results

RIV Capital Reports First Quarter Fiscal Year 2022 Financial Results

Cash balance of $212.5 million as at June 30th after completion of multiple monetization events during the quarter PharmHouse Credit Facility fully settled; Company anticipates receiving ~$6.5 million distribution upon termination of CCAA proceedings Strategic investment from The Hawthorne Collective announced subsequent to quarter end, f... Read More...
RIV Capital Announces US$150 Million Strategic Investment by The Hawthorne Collective, a Subsidiary of The Scotts Miracle-Gro Company

RIV Capital Announces US$150 Million Strategic Investment by The Hawthorne Collective, a Subsidiary of The Scotts Miracle-Gro Company

The Hawthorne Collective to purchase convertible note from RIV Capital to further RIV Capital's U.S. strategy Strengthened balance sheet accelerates RIV Capital's strategy to build a multistate cannabis operating and brand platform through acquisitions Transaction leverages RIV Capital's cannabis domain knowledge with ScottsMiracle-Gro's... Read More...
RIV Capital Sets Date for First Quarter Fiscal Year 2022 Financial Results

RIV Capital Sets Date for First Quarter Fiscal Year 2022 Financial Results

TORONTO, Aug. 3, 2021 - RIV Capital Inc. (the "Company" or "RIV Capital") (TSX: RIV) (OTC: CNPOF) will report its financial results for the quarter ended June 30, 2021 ("Q1 2022") before markets open on Monday, August 16, 2021. The Company's unaudited condensed interim consolidated financial statements and management's discussion and anal... Read More...
RIV Capital Portfolio Company ZeaKal Unveils Breakthrough High-Oil Hemp Results

RIV Capital Portfolio Company ZeaKal Unveils Breakthrough High-Oil Hemp Results

ZeaKal's novel PhotoSeed trait boosts hemp biomass oil output by up to 50% TORONTO and SAN DIEGO, June 1, 2021 - RIV Capital Inc. ("RIV Capital") (TSX: RIV) (OTC: CNPOF) portfolio company ZeaKal, Inc. ("ZeaKal") announced that its PhotoSeed‚ĄĘ technology is believed to be the first plant trait proven to enhance the oil profile of hemp, offe... Read More...
Canopy Rivers Reports Third Quarter Fiscal Year 2021 Financial Results

Canopy Rivers Reports Third Quarter Fiscal Year 2021 Financial Results

Comprehensive income of $82.2 million driven by significant increase in value of investment in TerrAscend Announced transformative and accretive transaction with Canopy Growth, expected to close by the end of February Anticipates being in strong financial and strategic position to pivot to the U.S. market following the closing of CGC Tran... Read More...
Canopy Rivers Sets Filing Date For Q3 Fiscal Year 2021 Financial Results

Canopy Rivers Sets Filing Date For Q3 Fiscal Year 2021 Financial Results

TORONTO, Jan. 27, 2021 - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV) (OTC: CNPOF) will report its third quarter fiscal year 2021 financial results before markets open on February 10, 2021. The Company's unaudited condensed interim consolidated financial statements and management's discussion and analysis of financial ... Read More...
Canopy Rivers Mails Circular for Special Meeting of Shareholders and Announces Receipt of Interim Court Order for Plan of Arrangement

Canopy Rivers Mails Circular for Special Meeting of Shareholders and Announces Receipt of Interim Court Order for Plan of Arrangement

TORONTO, Jan. 20, 2021 - Canopy Rivers Inc. ("Rivers" or the "Company") (TSX: RIV) (OTC: CNPOF) today filed and mailed the management information circular (the "Circular") and related materials in connection with the special meeting (the "Meeting") of shareholders to be held virtually on February 16, 2021 at 10:00 a.m. (Toronto time). In ... Read More...
Canopy Rivers to Monetize Certain Portfolio Assets for Total Transaction Value of Approximately $297 Million and Eliminate Dual Class Share Structure Pursuant to Agreement with Canopy Growth, Allowing Canopy Rivers to Shift Strategic Focus to Explore New Cannabis Markets Following Closing

Canopy Rivers to Monetize Certain Portfolio Assets for Total Transaction Value of Approximately $297 Million and Eliminate Dual Class Share Structure Pursuant to Agreement with Canopy Growth, Allowing Canopy Rivers to Shift Strategic Focus to Explore New Cannabis Markets Following Closing

Rivers to sell its interests in TerrAscend, Tweed Tree Lot, and Vert Mirabel to Canopy Growth at implied total transaction value of approximately $297 million, representing an aggregate ROIC of approximately 5.6x and IRR of approximately 101% Rivers to receive $115 million in cash and 3,750,000 common shares of Canopy Growth and cancel al... Read More...
Canopy Rivers Provides Update on PharmHouse Sale and Investment Solicitation Process, Debtor-in-Possession Financing

Canopy Rivers Provides Update on PharmHouse Sale and Investment Solicitation Process, Debtor-in-Possession Financing

TORONTO, Dec. 18, 2020 - Canopy Rivers Inc. ("Canopy Rivers'' or the "Company") (TSX: RIV) (OTC: CNPOF) today provided an update on its 49%-owned joint venture, PharmHouse Inc. ("PharmHouse"). On October 29, 2020, PharmHouse received a court order from the Ontario Superior Court of Justice (the "Court") to initiate a sale and investment ... Read More...
Canopy Rivers reports second quarter fiscal year 2021 financial results

Canopy Rivers reports second quarter fiscal year 2021 financial results

Aggregate charges of $112.3 million recognized on PharmHouse investments Appreciation of 101% in TerrAscend share price ‚Äď current implied TerrAscend investment value of $214.5 million1 Continued growth and expansion within portfolio TORONTO, Nov. 9, 2020 -¬†Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV) (OTC: CNPOF) today... Read More...
Canopy Rivers Sets Filing Date for Q2 Fiscal Year 2021 Financial Results

Canopy Rivers Sets Filing Date for Q2 Fiscal Year 2021 Financial Results

TORONTO, Nov. 2, 2020 - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV) (OTC: CNPOF) will report its second quarter fiscal year 2021 financial results before markets open on November 9, 2020. The Company's unaudited condensed interim consolidated financial statements and management's discussion and analysis of financial r... Read More...
Canopy Rivers Announces Results of Annual General and Special Meeting of Shareholders

Canopy Rivers Announces Results of Annual General and Special Meeting of Shareholders

Asha Daniere appointed Chair, Constellation Brands' CFO Garth Hankinson elected to Board of Directors TORONTO, Sept. 24, 2020 - Canopy Rivers Inc. (the "Company") (TSX: RIV) (OTC: CNPOF) announced the voting results of its annual general and special meeting of shareholders (the "Meeting") held today. In total, 59,090,152 of the Company's... Read More...
PharmHouse Pursues Formal Restructuring

PharmHouse Pursues Formal Restructuring

Joint venture seeks creditor protection while it restructures its business, financial obligations Canopy Rivers to provide up to $7.2 million in interim DIP financing TORONTO, Sept. 16, 2020 - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV) (OTC: CNPOF) announces that PharmHouse Inc. ("PharmHouse"), the Company's 49%-owne... Read More...
Canopy Rivers Announces Receipt of Statement of Claim in Respect of Pharmhouse Joint Venture

Canopy Rivers Announces Receipt of Statement of Claim in Respect of Pharmhouse Joint Venture

TORONTO, Sept. 14, 2020 - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") announced that it has received a statement of claim (the "Claim") filed by 2615975 Ontario Inc., the Company's joint venture partner in PharmHouse Inc. ("PharmHouse"), concerning certain disputes relating to PharmHouse. The Claim makes a number of allegations ... Read More...
Canopy Rivers Announces AGM Date

Canopy Rivers Announces AGM Date

TORONTO, Aug. 18, 2020 - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV) (OTC: CNPOF) will hold its annual general and special meeting (the "Meeting") of shareholders of the Company ("Shareholders") on September 24, 2020 at 10 a.m. (EDT). Electronic copies of all materials related to the Meeting can be found on the Compan... Read More...
Canopy Rivers Reports First Quarter Fiscal Year 2021 Financial Results

Canopy Rivers Reports First Quarter Fiscal Year 2021 Financial Results

Formed Special Committee to oversee investment in PharmHouse Enhanced strategic exposure to cannabis 2.0 through investment in Dynaleo Achieved significant progress toward operating expense reduction targets Well-positioned for U.S. market development through key successes at TerrAscend TORONTO, Aug. 14, 2020 - Canopy Rivers Inc. (the "Co... Read More...
Canopy Rivers Portfolio Companies Look to Expand Retail and Brand Presence in North American Markets

Canopy Rivers Portfolio Companies Look to Expand Retail and Brand Presence in North American Markets

Company provides update on Dynaleo, Agripharm, and TerrAscend TORONTO, July 10, 2020 - Three of Canopy Rivers Inc.'s ("Canopy Rivers") (TSX: RIV) (OTC: CNPOF) portfolio companies have made recent announcements as they aim to introduce new or expanded choices for cannabis consumers and medical patients in Canada and the U.S. "We continue t... Read More...
Deep Space Cannabis Beverage Has Launched

Deep Space Cannabis Beverage Has Launched

18H 36M 56.3364S, 38o 47' 01.291SMITHS FALLS, ON , June 16, 2020 - Deep Space, a full-flavoured cannabis beverage with 10 mg THC in a 222 mL aluminum vessel, has launched.Canopy Growth Logo (CNW Group/Canopy Growth Corporation)Deep Space is available for purchase on provincial ecommerce platforms and select cannabis retailers including Tw... Read More...
Canopy Rivers Reports Fourth Quarter and Fiscal Year 2020 Financial Highlights

Canopy Rivers Reports Fourth Quarter and Fiscal Year 2020 Financial Highlights

Strong financial position with $47 million cash on hand and no debt Commenced operational ramp-up at 1.3 million sq.ft. flagship joint venture Expanded ag-tech exposure in portfolio Significant corporate milestones, including graduation to the TSX and launch of Strategic Advisory Board TORONTO, June 3, 2020 - Canopy Rivers Inc. (the "Comp... Read More...
Coming Soon.
IndexLast% Change
S&P 5003,693.23--
Euro STOXX 503,342.430.18%Negative
FTSE 1006,964.730.77%Negative
Nikkei 22526,431.552.66%Negative

Delayed data (1h)
IndexLast% Change
S&P 5003,693.23--
Euro STOXX 503,342.430.18%Negative
FTSE 1006,964.730.77%Negative
Nikkei 22526,431.552.66%Negative


Share this page